Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control

References

1. ↵
   Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001; 3: 404–8.

   OpenUrlPubMedWeb of Science
2. ↵
   Israeli Ministry of Health Statistics. Morbidity. Available at http://www.health.gov.il/Download/pages/Morbidity.pdf. Accessed 23 September 2008.
3. ↵
   Israeli Diabetes Association [Homepage]. Available at http://www.sukeret.co.il/. Accessed 23 September 2008.
4. ↵
   Stern E, Raz I, Weitzman S. Prevalence of diabetes mellitus among workers in Israel: a nation-wide study. Acta Diabetol 1999; 36: 169–72.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977–86.

   OpenUrlCrossRefPubMedWeb of Science
6. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643–53.

   OpenUrlCrossRefPubMedWeb of Science
7. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837–53.

   OpenUrlCrossRefPubMedWeb of Science
8. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854–65.

   OpenUrlCrossRefPubMedWeb of Science
9. Andersson DK, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534–43.

   OpenUrlAbstract/FREE Full Text
10. ↵
    Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25: 1015–21.

    OpenUrlAbstract/FREE Full Text
11. ↵
    Winkler A, Teuscher AU, Mueller B, Diem P. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly 2002; 132: 379–85.

    OpenUrlPubMed
12. ↵
    Yamanouchi K, Shinozaki T, Chikada K, et al. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 1995; 18: 775–8.

    OpenUrlAbstract/FREE Full Text
13. ↵
    Kirk A, Mutrie N, MacIntyre P, Fisher M. Increasing physical activity in people with type 2 diabetes. Diabetes Care 2003; 26: 1186–92.

    OpenUrlAbstract/FREE Full Text
14. ↵
    Cardenas L, Vallbona C, Baker S, Yusim S. Adult onset diabetes mellitus: glycemic control and family function. Am J Med Sci 1987; 293: 28–33.

    OpenUrlPubMed
15. ↵
    Konen JC, Summerson JH, Dignan MB. Family function, stress, and locus of control. Relationships to glycemia in adults with diabetes mellitus. Arch Fam Med 1993; 2: 393–402.

    OpenUrlCrossRefPubMed
16. ↵
    Turan B, Osar Z, Molzan Turan J, Damci T, Ilkova H. The role of coping with disease in adherence to treatment regimen and disease control in type 1 and insulin treated type 2 diabetes mellitus. Diabetes Metab 2002; 28: 186–93.

    OpenUrlPubMed
17. ↵
    State of Israel Ministry of Health. Quality indicators for community health care in Israel. Public report 2005–2007. Available at http://www.health.gov.il/pages/default.asp?maincat=1&catId=98&PageId=4215. Accessed 3 October 2008.
18. ↵
    Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001; 285: 182–9.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Stern E, Benbassat CA, Goldfracht M. Impact of a two-arm educational program for improving diabetes care in primary care centres. Int J Clin Pract 2005; 59: 1126–30.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514–20.

    OpenUrlAbstract/FREE Full Text
21. ↵
    Larranaga I, Arteagoitia JM, Rodriguez JL, et al. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabet Med 2005; 22: 1047–53.

    OpenUrlCrossRefPubMedWeb of Science